Literature DB >> 16543221

Novel arylpyrazole compounds selectively modulate glucocorticoid receptor regulatory activity.

Jen-Chywan Wang1, Nilesh Shah, Carlos Pantoja, Sebastiaan H Meijsing, Joseph D Ho, Thomas S Scanlan, Keith R Yamamoto.   

Abstract

The activities of intracellular receptors are regulated by their cognate ligands. Here we show that a series of related arylpyrazole compounds, which specifically bind the glucocorticoid receptor (GR), selectively modulated GR-regulated biological functions in preadipocyte, pre-osteoblast, and lung epithelial cell lines. Indeed, when we monitored 17 endogenous GR target genes in one of these cell types, we found that distinct arylpyrazole compounds induced different expression patterns. We showed by chromatin immunoprecipitation that the arylpyrazole compounds regulated, in a gene-specific manner, either GR occupancy of the genomic glucocorticoid response element (GRE) or events after GR association, such as histone modification. Overall, our results establish that subtle differences in ligand chemistry can profoundly influence the transcriptional regulatory activity of GR, and that endogenous genes bearing natural GREs are especially sensitive detectors of these differences.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16543221      PMCID: PMC1413289          DOI: 10.1101/gad.1400506

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  34 in total

Review 1.  Mechanisms involved in the side effects of glucocorticoids.

Authors:  Heike Schäcke; Wolf Dietrich Döcke; Khusru Asadullah
Journal:  Pharmacol Ther       Date:  2002-10       Impact factor: 12.310

2.  The glucocorticoid receptor inhibits NFkappaB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain.

Authors:  R M Nissen; K R Yamamoto
Journal:  Genes Dev       Date:  2000-09-15       Impact factor: 11.361

3.  Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits interleukin-1beta-induced histone H4 acetylation on lysines 8 and 12.

Authors:  K Ito; P J Barnes; I M Adcock
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

4.  Down-regulation of the expression of endothelial NO synthase is likely to contribute to glucocorticoid-mediated hypertension.

Authors:  T Wallerath; K Witte; S C Schäfer; P M Schwarz; W Prellwitz; P Wohlfart; H Kleinert; H A Lehr; B Lemmer; U Förstermann
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

5.  Accessory factors facilitate the binding of glucocorticoid receptor to the phosphoenolpyruvate carboxykinase gene promoter.

Authors:  J M Stafford; J C Wilkinson; J M Beechem; D K Granner
Journal:  J Biol Chem       Date:  2001-08-22       Impact factor: 5.157

6.  Molecular determinants for the tissue specificity of SERMs.

Authors:  Yongfeng Shang; Myles Brown
Journal:  Science       Date:  2002-03-29       Impact factor: 47.728

Review 7.  The annexin-1 knockout mouse: what it tells us about the inflammatory response.

Authors:  F Roviezzo; S J Getting; M J Paul-Clark; S Yona; F N E Gavins; M Perretti; R Hannon; J D Croxtall; J C Buckingham; R J Flower
Journal:  J Physiol Pharmacol       Date:  2002-12       Impact factor: 3.011

8.  Human mesenchymal stem cells as an in vitro model for human adipogenesis.

Authors:  Lenka Janderová; Michele McNeil; Angela N Murrell; Randall L Mynatt; Steven R Smith
Journal:  Obes Res       Date:  2003-01

9.  Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A4 receptor.

Authors:  Mauro Perretti; Nan Chiang; Mylinh La; Iolanda M Fierro; Stefano Marullo; Stephen J Getting; Egle Solito; Charles N Serhan
Journal:  Nat Med       Date:  2002-10-07       Impact factor: 53.440

View more
  37 in total

1.  Identical gene regulation patterns of T3 and selective thyroid hormone receptor modulator GC-1.

Authors:  Chaoshen Yuan; Jean Z H Lin; Douglas H Sieglaff; Steven D Ayers; Frances Denoto-Reynolds; John D Baxter; Paul Webb
Journal:  Endocrinology       Date:  2011-11-08       Impact factor: 4.736

2.  Chromatin-dependent cooperativity between site-specific transcription factors in vivo.

Authors:  Pratibha B Hebbar; Trevor K Archer
Journal:  J Biol Chem       Date:  2006-12-23       Impact factor: 5.157

Review 3.  Signaling and transcriptional regulation in osteoblast commitment and differentiation.

Authors:  Wei Huang; Shuying Yang; Jianzhong Shao; Yi-Ping Li
Journal:  Front Biosci       Date:  2007-05-01

Review 4.  Minireview: latest perspectives on antiinflammatory actions of glucocorticoids.

Authors:  Karolien De Bosscher; Guy Haegeman
Journal:  Mol Endocrinol       Date:  2008-12-18

Review 5.  Signaling networks that control the lineage commitment and differentiation of bone cells.

Authors:  Carrie S Soltanoff; Shuying Yang; Wei Chen; Yi-Ping Li
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2009       Impact factor: 1.807

Review 6.  Allosteric pathways in nuclear receptors - Potential targets for drug design.

Authors:  Elias J Fernandez
Journal:  Pharmacol Ther       Date:  2017-10-31       Impact factor: 12.310

Review 7.  Crosstalk in inflammation: the interplay of glucocorticoid receptor-based mechanisms and kinases and phosphatases.

Authors:  Ilse M E Beck; Wim Vanden Berghe; Linda Vermeulen; Keith R Yamamoto; Guy Haegeman; Karolien De Bosscher
Journal:  Endocr Rev       Date:  2009-11-04       Impact factor: 19.871

8.  Thiazolidinediones are partial agonists for the glucocorticoid receptor.

Authors:  L Matthews; A Berry; M Tersigni; F D'Acquisto; A Ianaro; D Ray
Journal:  Endocrinology       Date:  2008-09-18       Impact factor: 4.736

9.  Deacylcortivazol-like pyrazole regioisomers reveal a more accommodating expanded binding pocket for the glucocorticoid receptor.

Authors:  Jessica A O Zimmerman; Mimi Fang; Bintou Doumbia; Alexis Neyman; Ji Hyeon Cha; Michael Thomas; Bonnie Hall; Meng Wu; Anne M Wilson; Miles A Pufall
Journal:  RSC Med Chem       Date:  2020-12-08

10.  Angiopoietin-like 4 (ANGPTL4, fasting-induced adipose factor) is a direct glucocorticoid receptor target and participates in glucocorticoid-regulated triglyceride metabolism.

Authors:  Suneil K Koliwad; Taiyi Kuo; Lauren E Shipp; Nora E Gray; Fredrik Backhed; Alex Yick-Lun So; Robert V Farese; Jen-Chywan Wang
Journal:  J Biol Chem       Date:  2009-07-23       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.